Silver
Booth No. Academy Field Category Product Property CategoryAddress | #1101, (Hi Brand Living Bldg.) 16, Maeheon-ro, Seocho-gu, Seoul, 06771, Korea | ||
---|---|---|---|
Telephone | +82-1899-9217 | Fax | +82-2-2155-0571 |
Website | www.werfen.com/kr | werfenkorea@werfen.com |
Werfen at a glance. Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain. We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics and Autoimmunity. Through our Original Equipment Manufacturing (OEM) business line, we research, develop and manufacture customized assays and biomaterials. At present, we operate directly in nearly 30 countries and in more than 100 territories through distributors. Our R&D and production centers are located in the United States and Europe. In 2020, our revenues were € 1.696 billion and our workforce is 5,501 strong. We have made some exciting changes: our entire organization is now unified as one Company, with one name and one brand—Werfen. While Instrumentation Laboratory, Inova Diagnostics and Biokit have been Werfen companies for many years, we will now all be known as Werfen, with the same vision and mission. Our new strong and singular logo signifies unity in our quest to deliver innovation after innovation, enhancing patient care around the world. In the midst of these changes, it is important to reinforce: we remain, steadfastly, a Specialized Diagnostics company. One Company. One Team. One Name.
Minimize errors and enhance quality. The new ACL TOP Family 50 Series* offers the most advanced automation and quality management for routine-to-specialty Hemostasis testing. Engineered to minimize errors and enhance quality, all models are standardized and offer automated pre-analytical sample integrity checks. Plus, all ACL TOP 50 Series systems are optimized for a comprehensive panel of HemosIL assays to offer a complete disease-state management solution.
The Intelligent Analyzer Assuring quality before, during and after sample analysis for improved patient care. GEM Premier 5000* Critical Care whole-blood testing system provides automated quality assurance with every sample. Now with next-generation Intelligent Quality Management (iQM2), featuring IntraSpect™ technology, potential errors are detected not only before and after, but also during sample analysis, along with real-time correction and documentation. Plus, It’s simple—just change the all-in-one GEM PAK once a month. So regardless of testing location or point-of-care operator, quality results and compliance are assured with every sample.